Texas Oncology Central/South — Austin, Texas

Texas Oncology Central/South is a clinical research site located in Austin, Texas, United States 78705.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology Central/South has participated in 61 clinical trials with 52 currently active.

Therapeutic areas: Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche, Coherus Oncology, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Austin

Browse all research sites in Texas · View every site in Austin

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology Central/South?

Texas Oncology Central/South has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology Central/South conducted?

Texas Oncology Central/South has 61 clinical trials on record, with 52 currently active. Their work covers Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck.

Is Texas Oncology Central/South accredited by Crixeo Clinical Trials?

Texas Oncology Central/South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology Central/South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.